GSK Annual Report 2002
GSK Annual Report 2002
GSK Annual Report 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
37 Reconciliation to US accounting principles continued<br />
Notes to the financial statements GlaxoSmithKline 131<br />
Purchase accounting adjustments £m<br />
Total assumed purchase consideration for outstanding shares (a) 43,919<br />
Costs and fees of transaction<br />
Less:<br />
66<br />
Book value of SmithKline Beecham net assets – US GAAP (less goodwill) 2,742<br />
Excess fair value of inventory (b) 267<br />
Excess fair value of tangible fixed assets (b) 15<br />
Excess fair value of investments (c) 1,042<br />
Excess fair value of pension asset (d) 81<br />
Fair value attributed to other intangible assets (e) 24,382<br />
Fair value attributed to workforce (now considered goodwill) (e) 483<br />
Fair value attributed to in-process R&D projects (f) 6,324<br />
Additional liabilities assumed (g) (110)<br />
Deferred tax liabilities related to purchase price adjustments (h) (7,669)<br />
Goodwill (i) 16,428